RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TONINI G
Collezione AO Cuneo

Items : 11

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. in Cancers / Cancers (Basel). 2023 Jun 15;15(12):3206. doi: 10.3390/cancers15123206.

2023
AO Cuneo

Muscaritoli M; Modena A; Valerio M; Marchetti P; Magarotto R; Quadrini S; Narducci F; Tonini G; Grassani T; Cavanna L; Di Nunzio C; Citterio C; Occelli M; Strippoli A; Chiurazzi B; Frassoldati A; Altavilla G; Lucenti A; Nicolis F; Gori S;

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. in Scientific reports / Sci Rep. 2021 Jul 2;11(1):13770. doi: 10.1038/s41598-021-92774-z.

2021
AO Cuneo

Pizzuti L; Barba M; Mazzotta M; Krasniqi E; Maugeri-Saccà M; Gamucci T; Berardi R; Livi L; Ficorella C; Natoli C; Cortesi E; Generali D; La Verde N; Cassano A; Bria E; Moscetti L; Michelotti A; Adamo V; Zamagni C; Tonini G; Sergi D; Marinelli D; Paoletti G; Tomao S; Botticelli A; Marchetti P; Tinari N; Grassadonia A; Valerio MR; et alii...

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2020 Dec 10;39(1):279. doi: 10.1186/s13046-020-01797-3.

2020
AO Cuneo

Del Medico P; Cazzaniga M; Garufi C; Sarobba G; Giotta F; Paris I; Garrone O; Veltri E; Corsi D; D'Ostilio N; Fabbri MA; Russo A; Mirabelli R; Valerio MR; Marchetti P; Tomao S; Marinelli D; Mazzotta M; Barchiesi G; Zamagni C; Tonini G; Adamo V; Michelotti A; Moscetti L; Bria E; Cassano A; La Verde N; Generali D; Cortesi E; et alii...

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Mar;109:175-182. doi: 10.1016/j.ejca.2018.12.028. Epub 2019 Feb 5.

2019
AO Cuneo

Lonardi S; Sensi E; Tonini G; Di Donato S; Schirripa M; Delfanti S; Granetto C; Gemma D; Casagrande M; Borelli B; Allegrini G; Murgioni S; Antoniotti C; Dell'Aquila E; Salvatore L; Masi G; Aprile G; Bergamo F; Cremolini C; Marmorino F; Fontanini G; Boni L; Falcone A;

Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study. in Tumori / Tumori. 2019 Jun;105(3):243-252. doi: 10.1177/0300891619834126. Epub 2019 Mar 11.

2019
AO Cuneo
AOU Città della Salute di Torino

Tonini G; Bergamo F; Proietti E; Proserpio I; Ballestrero A; Biglietto M; Lucchesi S; Granetto C; Ciuffreda L; Fagnani D; Gemma D; Nasti G; Lonardi S;

Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. in Cancers / Cancers (Basel). 2018 Jun 1;10(6):175. doi: 10.3390/cancers10060175.

2018
AO Cuneo
ASL Alessandria
AOU Città della Salute di Torino

Aielli F; Valle A; Tonini G; Sofia M; Papa A; Scelzi E; Ricci S; Orsetti R; De Santis S; Pascoletti G; Moroso S; Menardo V; Miotti D; Melotti RM; Mattioli R; Mazzei T; Masedu F; Mameli S; Palermo L; Liguori S; Guardamagna V; Iaffaioli V; Fusco F; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Blasi L; Bandera M; et alii...

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Jul;29(7):1528-1534. doi: 10.1093/annonc/mdy140. Epub 2018 Apr 20.

2018
AO Cuneo
AOU Città della Salute di Torino

Falcone A; Fontanini G; Boni L; Sensi E; Zagonel V; Masi G; Allegrini G; Granetto C; Buonadonna A; Marmorino F; Tonini G; Zaniboni A; Loupakis F; Ronzoni M; Racca P; Moretto R; Cortesi E; Tomasello G; Lonardi S; Bergamo F; Antoniotti C; Cremolini C; Cremolini C; Antoniotti C; Lonardi S; Bergamo F; Cortesi E; Tomasello G; Moretto R; et alii...

Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Mar;73:74-84. doi: 10.1016/j.ejca.2016.10.028. Epub 2016 Dec 13.

2017
AO Cuneo

Cremolini C; Casagrande M; Loupakis F; Aprile G; Bergamo F; Masi G; Moretto R R; Pietrantonio F; Marmorino F; Zucchelli G; Tomasello G; Tonini G; Allegrini G; Granetto C; Ferrari L; Urbani L; Cillo U; Pilati P; Sensi E; Pellegrinelli A; Milione M; Fontanini G; Falcone A;

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS). in Advances in therapy / Adv Ther. 2017 Jan;34(1):120-135. doi: 10.1007/s12325-016-0440-4. Epub 2016 Nov 21.

2017
AO Cuneo
AOU Città della Salute di Torino

Valle A; Aielli F; Tonini G; Sofia M; Scelzi E; Sabato AF; Ricci S; Orsetti R; Papa A; De Santis S; Moroso S; Menardo V; Miotti D; Melotti RM; Mazzei T; Mattioli R; Mameli S; Lorusso V; Iaffaioli V; Liguori S; Fusco F; Guardamagna V; Degiovanni D; Costanzo BVP; Cartenì G; Chiurazzi B; Blasi L; Bandera M; Azzarello G; et alii...

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 May;27(5):843-9. doi: 10.1093/annonc/mdw052. Epub 2016 Feb 9.

2016
AO Cuneo
AOU Città della Salute di Torino

Bustreo S; Ronzoni M; Buonadonna A; Bergamo F; Tomasello G; Tonini G; Allegrini G; Vitello S; Rossini D; Moretto R; Chiara S; Mancini ML; Granetto C; Lonardi S; Masi G; Loupakis F; Cremolini C; Barbara C; Boni L; Falcone A;

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jun;26(6):1188-1194. doi: 10.1093/annonc/mdv112. Epub 2015 Feb 23.

2015
AO Cuneo
AOU Città della Salute di Torino

Di Donato S; Granetto C; Bonetti A; D'Amico M; Vitello S; Longarini R; Barone C; Tonini G; Spadi R; Zaniboni A; Tomasello G; Cortesi E; Salvatore L; Masi G; Lonardi S; Antoniotti C; Cremolini C; Loupakis F; Boni L; Falcone A;